View the file

Other files

File Type Posted
Xofigo JA FY21 Philadelphia Redacted_Redacted.pdf PDF

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Contract Opportunity Special Notice

PRODUCT SERVICE CODE

SUBJECT

CONTRACTING OFFICE'S

ZIP-CODE

SOLICITATION NUMBER

ARCHIVE

DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

NAICS CODE

CONTRACTING OFFICE

ADDRESS

POINT OF CONTACT

(POC Information Automatically Filled from User Profile Unless Entered)

DESCRIPTION

See Attachment

AGENCY'S URL

URL DESCRIPTION

AGENCY CONTACT'S EMAIL

ADDRESS

EMAIL DESCRIPTION

GENERAL INFORMATION

ADDITIONAL INFORMATION

* = Required Field Contract Opportunity Special Notice Xofigo Radium Ra-223 Dichloride injections | EDA: 1/5/2021 | Status: Creating FAR8 Brand Name Justification (11/30/20 alt). Preparing Market Research Report (11/27/20 alt).

15240 36C24421Q0136 N 325412 Department of Veterans Affairs Network Contracting Office 4 1010 Delafield Road Pittsburgh PA 15240 Andrew Taylor andrew.taylor3@va.gov https://www.va.gov/pittsburgh-health-care/ Pittsburgh VA Medical Center andrew.taylor3@va.gov Contracting Officer A firm-fixed price, sole source purchase order for Xofigo Injection 6 ML/vial (Radium Ra-223 Dichloride injection 6ml/vial, National Drug Code: 50419-0208-01), will be awarded directly to Cardinal Health 414. Bayer HealthCare Pharmaceuticals, Inc. is the manufacture and Cardinal Health 414, LLC. is the only authorized distributor of Xofigo.

See attached document: Xofigo JA FY21 Philadelphia Redacted_Redacted.

End of Document

File details come from the government source that posted it. Updated .